SPRO (STOCKS)
Spero Therapeutics, Inc. Common Stock
$1.130000
+0.010000 (+0.89%)
Prev close: $1.120000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Esther Rajavelu
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $66.10M
- Employees
- 32
- P/E (TTM)
- 10.26
- P/B (TTM)
- 1.47
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.16 | $-0.17 | +0.0134 | +7.73% |
|
Mar 2026 (Q1)
|
$-0.13 | $-0.18 | +0.0536 | +29.19% |
|
Dec 2025 (Q4)
|
$0.53 | $-0.20 | +0.7340 | +359.80% |
|
Sep 2025 (Q3)
|
$-0.13 | $-0.26 | +0.1250 | +49.02% |